Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

30 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Reference Susceptibility Testing and Genomic Surveillance of Clostridioides difficile, United States, 2012-17.
Gargis AS, Karlsson M, Paulick AL, Anderson KF, Adamczyk M, Vlachos N, Kent AG, McAllister G, McKay SL, Halpin AL, Albrecht V, Campbell D, Korhonen LC, Elkins CA, Rasheed JK, Guh AY, McDonald LC, Lutgring JD; Emerging Infections Program C. difficile Infection Working Group. Gargis AS, et al. Clin Infect Dis. 2023 Mar 4;76(5):890-896. doi: 10.1093/cid/ciac817. Clin Infect Dis. 2023. PMID: 36208202 Free PMC article.
Difficult-To-Detect Staphylococcus aureus: mecA-Positive Isolates Associated with Oxacillin and Cefoxitin False-Susceptible Results.
Gargis AS, Yoo BB, Lonsway DR, Anderson K, Campbell D, Ewing TO, Lawsin A, Machado MJ, Yamamoto N, Halpin AL, Lutgring JD, Karlsson M, Rasheed JK, Elkins CA. Gargis AS, et al. J Clin Microbiol. 2020 Mar 25;58(4):e02038-19. doi: 10.1128/JCM.02038-19. Print 2020 Mar 25. J Clin Microbiol. 2020. PMID: 31996449 Free PMC article. No abstract available.
Characterization of Clostridioides difficile Isolates Available through the CDC & FDA Antibiotic Resistance Isolate Bank.
Paulick A, Adamczyk M, Anderson K, Vlachos N, Machado MJ, McAllister G, Korhonen L, Guh AY, Halpin AL, Rasheed JK, Karlsson M, Lutgring JD, Gargis AS; Emerging Infections Program Clostridioides difficile Pathogen Group. Paulick A, et al. Among authors: gargis as. Microbiol Resour Announc. 2021 Jan 7;10(1):e01011-20. doi: 10.1128/MRA.01011-20. Microbiol Resour Announc. 2021. PMID: 33414286 Free PMC article.
Effects of Patient Characteristics on Diagnostic Performance of Self-Collected Samples for SARS-CoV-2 Testing.
Smith-Jeffcoat SE, Koh M, Hoffman A, Rebolledo PA, Schechter MC, Miller HK, Sleweon S, Rossetti R, Kasinathan V, Shragai T, O'Laughlin K, Espinosa CC, Khalil GM, Adeyemo AO, Moorman A, Bauman BL, Joseph K, O'Hegarty M, Kamal N, Atallah H, Moore BL, Bohannon CD, Bankamp B, Hartloge C, Bowen MD, Paulick A, Gargis AS, Elkins C, Stewart RJ, da Silva J, Biedron C, Tate JE, Wang YF, Kirking HL; CDC COVID-19 Response Team. Smith-Jeffcoat SE, et al. Among authors: gargis as. Emerg Infect Dis. 2021;27(8):2081-2089. doi: 10.3201/eid2708.210667. Emerg Infect Dis. 2021. PMID: 34286681 Free PMC article.
Sentinel Surveillance Reveals Emerging Daptomycin-Resistant ST736 Enterococcus faecium and Multiple Mechanisms of Linezolid Resistance in Enterococci in the United States.
Gargis AS, Spicer LM, Kent AG, Zhu W, Campbell D, McAllister G, Ewing TO, Albrecht V, Stevens VA, Sheth M, Padilla J, Batra D, Johnson JK, Halpin AL, Rasheed JK, Elkins CA, Karlsson M, Lutgring JD. Gargis AS, et al. Front Microbiol. 2022 Feb 1;12:807398. doi: 10.3389/fmicb.2021.807398. eCollection 2021. Front Microbiol. 2022. PMID: 35178041 Free PMC article.
Correction for Paulick et al., "Characterization of Clostridioides difficile Isolates Available through the CDC & FDA Antibiotic Resistance Isolate Bank".
Paulick A, Adamczyk M, Anderson K, Vlachos N, Machado MJ, McAllister G, Korhonen L, Guh AY, Halpin AL, Rasheed JK, Karlsson M, Lutgring JD, Gargis AS; Emerging Infections Program Clostridioides difficile Pathogen Group. Paulick A, et al. Among authors: gargis as. Microbiol Resour Announc. 2022 May 19;11(5):e0030222. doi: 10.1128/mra.00302-22. Epub 2022 Apr 27. Microbiol Resour Announc. 2022. PMID: 35475673 Free PMC article. No abstract available.
Reply to Gonzales-Luna et al.
Gargis AS, Karlsson M, Kamile Rasheed J, Kent AG, McKay SL, Paulick AL, Anderson KF, Adamczyk M, Campbell D, Korhonen LC, McAllister G, Vlachos N, Halpin AL, Lutgring JD, Guh AY, Clifford McDonald L, Elkins CA. Gargis AS, et al. Clin Infect Dis. 2023 Jun 8;76(11):2039-2041. doi: 10.1093/cid/ciad133. Clin Infect Dis. 2023. PMID: 36883575 Free PMC article. No abstract available.
Complete genome sequences of Clostridioides difficile surveillance isolates representing the top 10 ribotypes from the Emerging Infections Program, United States, 2016.
Adamczyk M, Vlachos N, Breaker E, Orazi G, Paulick AL, Rowe LA, McAllister G, Machado M-J, Korhonen L, Guh AY, Rasheed JK, Karlsson M, McKay SL, Lutgring JD, Gargis AS; Emerging Infections Program Clostridioides difficile Pathogen Group. Adamczyk M, et al. Among authors: gargis as. Microbiol Resour Announc. 2024 Jul 18;13(7):e0112823. doi: 10.1128/mra.01128-23. Epub 2024 May 29. Microbiol Resour Announc. 2024. PMID: 38809010 Free PMC article.
Genomic Epidemiology of Extrapulmonary Nontuberculous Mycobacteria Isolates at Emerging Infections Program Sites - United States, 2019-2020.
Masters TL, Toney NC, Ewing TO, McAllister G, Mathis MH, Grigg C, Magill SS, Jackson KA, Byram R, See I, Salfinger M, Barter D, Johnston H, Lynfield R, Vagnone PS, Tourdot L, Anderson BJ, Dumyati G, Pierce R, Lutgring JD, Gargis A, McKay S. Masters TL, et al. J Infect Dis. 2024 Oct 7:jiae488. doi: 10.1093/infdis/jiae488. Online ahead of print. J Infect Dis. 2024. PMID: 39373703
30 results